September 28, 2018
Theranos, once valued at more than $9B, has run out of money, employees and time. It will formally disband in the coming months, according to The […]
September 28, 2018
As predicted in a recent report by EvaluatePharma, the top 10 drugmakers in 2024 will hold a combined 35% of the total biopharma market share – […]
September 28, 2018
As Takeda works to close its acquisition of Shire, the company plans to move its Chicago-area U.S. headquarters and center its U.S. operations in the Boston […]
September 28, 2018
Novartis says that four traditional pill manufacturing plants in Switzerland and one in the U.K. will be hit with job cuts as it trims down a […]
September 28, 2018
Alexion Pharmaceuticals Inc. will buy privately held biotech Syntimmune for a total price of up to $1.2B, strengthening its rare disease portfolio. This will give Alexion […]
October 4, 2018
This year’s Fierce 15 winners saw a total of $1.36B in funding rounds and capital commitments, four of which topped $100M. This proves that these exciting […]
October 19, 2018
Sanofi Genzyme is looking to expand its rare disease footprint in Cambridge, MA, with 400,000 sq. ft. of office and lab space that could house about […]
November 8, 2018
Things are looking up for women, but while they fill half of the life science industry’s entry-level positions, females make up only 20% of leadership teams […]
November 8, 2018
After six years, Shire’s $1B plasma fractionation plant in Georgia is now officially open. The company confirmed that the plant currently has about 900 employees and […]